{"nct_id":"NCT04926831","title":"Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2022-08-10","start_date_type":"ACTUAL","primary_completion_date":"2024-03-13","primary_completion_date_type":"ACTUAL","completion_date":"2024-03-13","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}